几种天然产物的抑菌性能研究

将羧甲基壳聚糖等四种天然产物作为供试样,分别测定其对大肠杆菌、金黄色葡萄球菌、绿脓杆菌、枯草杆菌的最低抑菌浓度,结果表明,四种供试样对其均有一定的抑制作用,其中壳寡糖对大肠杆菌、金黄色葡萄球菌、枯草杆菌的抑制作用最强,羧甲基壳聚糖、壳寡糖、白芨多糖对绿脓杆菌的抑制能力差不多。再根据单体实验结果,选择羧甲基壳聚糖、壳寡糖、白芨多糖进行两两复配实验,结果表明,壳寡糖与白芨多糖的复配液对于金黄色葡萄球菌、枯草杆菌有较明显的协同增效抑菌作用。     

硫脲壳聚糖Zn(Ⅱ)配合物的制备、表征及生物活性

利用FT-IR、UV、TG-DTA和XRD手段,对合成的硫脲壳聚糖及硫脲壳聚糖-Zn(Ⅱ)配合物进行了表征,研究了壳聚糖、硫脲壳聚糖及硫脲壳聚糖-Zn(Ⅱ)配合物对细菌大肠杆菌、金黄色葡萄球菌和真菌黑曲霉的抑菌性能.结果表明:合成的硫脲壳聚糖-Zn(Ⅱ)配合物对大肠杆菌、金黄色葡萄球菌的抑菌性能比单一的壳聚糖、硫脲壳聚糖显著提高,对真菌黑曲霉亦具有较强的抑制作用.     

低聚壳聚糖美拉德衍生物抑菌性能研究

本文研究了基于与葡萄糖、麦芽糖和木糖进行美拉德反应的低聚壳聚糖衍生物的抑菌性.测定低聚壳聚糖及其衍生物对大肠杆菌和金黄色葡萄球菌的抑制效果.结果显示:壳聚糖及其衍生物对金黄色葡萄球菌的抑制作用强于对大肠杆菌的抑制作用,且随着浓度增加,对两种菌的抑菌效果增强.大多数壳聚糖衍生物的抑菌效果优于壳聚糖本身,其中CG 1∶1 8 h(低聚壳聚糖的氨基与葡萄糖的羰基的物质量比为1∶1,反应8h)的抑菌效果最好,CM 1∶3 8 h(低聚壳聚糖的氨基与麦芽糖的羰基的物质量比为1∶3,反应8 h)抑菌性最差,这可能与参加反应的还原糖种类、反应物比例以及反应时间相关.     

壳聚糖Fe（Ⅲ）配合物的合成、表征及抑菌性能

合成了壳聚糖Fe(Ⅲ)配合物,利用IR、UV、和TG-DTA对配合物进行了表征.研究了壳聚糖及壳聚糖铁(Ⅲ)配合物对常见的两种细菌(大肠杆菌、金黄色葡萄球菌)的抑菌性能.结果表明:水溶性的壳聚糖在配合前后,其结构表征发生了一定的变化,并且壳聚糖铁(Ⅲ)配合物的抑菌性能比水溶性壳聚糖本身显著提高(P＜0.05).     

壳聚糖抑菌机制的初步研究

壳聚糖在医学、食品、环保、日化用品等领域有着广泛而重要的应用.近年来,壳聚糖由于对不同的菌类都具有良好的抑菌效果而被研究者们密切关注.然而,有关壳聚糖抑菌机制的研究却并不多,其抑菌机制也没有被完全阐明.在本研究中,我们发现很多金属离子可以对壳聚糖的抑菌效果产生影响,高浓度金属离子(0.5%)可以使壳聚糖完全丧失抑菌活性.还发现金黄色葡萄球菌和白色念珠菌在壳聚糖的作用下会发生钾离子和ATP的渗漏,而且五万分子量的壳聚糖引起钾离子和ATP的渗漏大约比五千分子量壳聚糖多2到4倍.不同分子量的壳聚糖对金黄色葡萄球菌和白色念珠菌都具有较好的抑菌效果,但是引起钾离子和ATP的渗漏量却存在很大差异,这说明小分子量壳聚糖很可能存在与大分子量壳聚糖不同的抑菌机制.     

白色念珠菌拮抗菌株的筛选

目的筛选对白色念珠菌具有明显拮抗作用的菌株.方法通过纸片琼脂扩散法(K-B法)观察各菌株对白色念珠菌的拮抗作用;再利用试管法观察有拮抗作用菌株对白色念珠菌的抑菌效果.结果 K-B法表明大肠埃希菌、甲型链球菌和卡他球菌对白色念珠菌无抑菌作用,表皮葡萄球菌、微球菌有抑菌作用,但抑菌环小;枯草杆菌有明显抑菌作用.试管法表明表皮葡萄球菌和枯草杆菌对白色念珠菌均有生物拮抗作用,其抑菌率分别为97%和89.7%.结论枯草杆菌是白色念珠菌的理想拮抗菌株.     

壳聚糖中胺基对其抑菌性能的影响及与DNA的作用

采用抑菌圈法研究了壳聚糖对大肠杆菌(E.coli)和金黄色葡萄球菌(St.aureus)的抑菌活性。利用壳聚糖的席夫碱反应,对壳聚糖的胺基进行保护后,研究了壳聚糖中胺基对其抑菌性能的影响。同时,运用紫外吸收光谱和电化学的方法,研究了壳聚糖与DNA的相互作用,提出了壳聚糖对E.coli和St.aureus的抑菌机理。研究结果表明,壳聚糖对E.coli和St.aureus具有很好的抑制作用,且抑菌活性与其胺基有关;壳聚糖能与细胞内带负电的核酸结合,使细胞正常DNA复制生理功能受到影响,抑制细菌的繁殖,从而达到抑菌的目的。     

不同分子量壳聚糖对五种常见菌的抑制作用研究

体外抑菌法研究了六种不同相对分子量的壳聚糖对金黄色葡萄球菌、大肠杆菌、绿脓杆菌、白色念珠菌、变形杆菌的抑菌活性,并对壳聚糖的抑菌机理做了探讨。     

天竺桂挥发油化学成分及抑菌活性研究

用水蒸馏法提取天竺桂(CinnamomumjaponicumSibe)挥发油,并用GC-MS分析化学成分,用滤纸片法测其抑菌活性。结果表明,从天竺桂挥发油中分离出27种化学成分,以冰片为主要成分,占26.03%;抑菌实验中,挥发油对大肠杆菌、枯草杆菌和金黄色葡萄球菌都有明显的抑菌作用。     

不同分子量壳聚糖对五种常见茵的抑制作用研究

体外抑菌法研究了六种不同相对分子量的壳聚糖对金黄色葡萄球菌、大肠杆菌、绿脓杆菌、白色念珠菌、变形杆菌的抑菌活性,并对壳聚糖的抑菌机理做了探讨.     

海金沙提取物体外抑菌性能研究

用M／C和纸片法考查了海金沙提取物对藤黄球菌、枯草芽孢杆菌、金黄色葡萄球菌和乙型溶血性链球菌的抑菌性能。结果表明：海金沙对4种受试菌株都有抑菌活性;37℃时,醇提物对乙型溶血性链球菌的抑菌效果最好,最大抑菌圈为8．5mm;42℃时,对藤黄球菌、金黄色葡萄球菌和枯草杆菌的抑菌效果最好,最大抑菌圈分别为21、13．2和6．5mm。pH值为7．6时,海金沙醇提物在对藤黄球菌、金黄色葡萄球菌、枯草杆菌和乙型溶血性链球菌的最大抑菌圈分别为9．1、8．2、9mm和11．3mm。海金沙水提物和醇提物对藤黄球菌、乙型溶血性链球菌、枯草芽孢杆菌、金黄色葡萄球菌的最低抑菌质量分数分别为25％、12．5％、12．5％、25％和3．12％、1．56％、6．25％、3．12％．     

Synthesis, antimicrobial and anticancer activities of a novel series of diphenyl 1-(pyridin-3-yl)ethylphosphonates

A novel series of diphenyl 1-(arylamino)-1-(pyridin-3-yl)ethylphosphonates 1-5 was obtained in high yields from reactions of 3-acetyl pyridine with aromatic amines and triphenylphosphite in the presence of lithium perchlorate as a catalyst. The structures of the synthesized compounds were confirmed by IR, (1)H NMR spectral data and microanalyses. Compounds 1-5 showed high antimicrobial activities against Escherichia coli (NCIM2065) as a Gram-negative bacterium, Bacillus subtilis (PC1219) and Staphylococcus aureus (ATCC25292) as Gram-positive bacteria and Candidaalbicans and Saccharomyces cerevisiae as fungi, at low concentrations (10-100 μg/mL). Also, the synthesized compounds showed significant cytotoxicity anticancer activities against liver carcinoma cell line (HepG2) and human breast adenocarcinoma cell line (MCF7). The lethal dose of the synthesized compounds was also determined and indicated that most compounds are safe to use.     

Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents

A new series of N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamide and phenylacetamide derivatives (1a-1n, 2a-2n) were synthesized and evaluated for antibacterial and antifungal activities against Staphylococcus aureus, Bacillus subtilis, Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Candida albicans, and their drug-resistant isolate. Microbiological results indicated that the compounds possessed a broad spectrum of activity against the tested microorganisms at MIC values between 500 and 1.95 microg/ml. Benzamide derivative 1d exhibited the greatest activity with MIC values of 1.95, 3.9, and 7.8 microg/ml against drug-resistant B. subtilis, B. subtilis, and S. aureus, respectively.     

Synthesis and antibacterial activity of 1-[1,2,4-triazol-3-yl] and 1-[1,3,4-thiadiazol-2-yl]-3-methylthio-6,7-dihydrobenzo[c]thiophen-4(5H)ones

A series of 1-[1,2,4-triazol-3-yl] and 1-[1,3,4-thiadiazol-2-yl]-3-methylthio-6,7-dihydrobenzo[c]thiophen-4(5H)ones were synthesized and tested to demonstrate in vitro antimicrobial activity. Some of these compounds exhibited a good activity against Staphylococcus aureus, S. epidermidis and Bacillus subtilis.     

Antibacterial dimeric copper(II) complexes with chromone-derived compounds

A new series of six chromone-derived compounds and their Cu(II) complexes have been synthesized and characterized by their physical, spectral and analytical data. The ligands and their Cu(II) complexes were screened for their in vitro antibacterial activity against four Gram-negative (Escherichia coli, Pseudomonas aeruginosa, Salmonella typhi, Shigella flexneri) and two Gram-positive (Bacillus subtilis, Staphylococcus aureus) bacterial strains by agar-well diffusion method. The ligands were found to exhibit either no or low-to-moderate activities against one or more bacterial species whereas, the Cu(II) complexes exhibited moderate-to-high activity. The ligands which were inactive before complexation became active upon complexation with the Cu(II) metal ion and less active became more active.     

Synthesis, characterization and biological properties of thienyl derived triazole Schiff bases and their oxovanadium(IV) complexes

A new series of biologically active thienyl derived triazole Schiff bases and their oxovanadium(IV) complexes have been synthesized and characterized on the basis of physical (m.p., magnetic susceptibility and conductivity), spectral (IR, 1H and 13C NMR, electronic and mass spectrometry) and microanalytical data. All the Schiff base ligands and their oxovanadium(IV) complexes have been subjected to in vitro antibacterial activity against four Gram-negative (Escherichia coli, Shigella flexneri, Pseudomonas aeruginosa, Salmonella enterica serover typhi) and two Gram-positive (Staphylococcus aureus and Bacillus subtilis) bacterial strains and, for in vitro antifungal activity against Trichophyton longifucus, Candida albican, Aspergillus flavus, Microscopum canis, Fusarium solani and Candida glabrata. Brine shrimp bioassay was also carried out to check the cytotoxic nature of these compounds.     

In-vitro antibacterial, antifungal and cytotoxic properties of metal-based furanyl derived sulfonamides

A new series of antibacterial and antifungal furanyl-derived sulfonamides and their cobalt (II), copper (II), nickel (II) and zinc (II) metal complexes have been synthesized, characterized and screened for their in-vitro antibacterial activity against four Gram-negative (Escherichia coli, Shigella flexneri, Pseudomonas aeruginosa and Salmonella typhi) and two Gram-positive (Bacillus subtilis and Staphylococcus aureus) bacterial strains and, for in-vitro antifungal activity against Trichophyton longifusus, Candida albicans, Aspergillus flavus, Microsporum canis, Fusarium solani and Candida glaberata. The results of these studies revealed that all compounds showed significant to moderate antibacterial activity. However, the zinc (II) complexes were found to be comparatively much more active as compared to the others. For antifungal activity generally, compounds (22) and (24) showed significant activity against Escherichia coli (a), (6) against Shigella flexeneri (b), (16) and (22) against Pseudomonas aeruginosa (c), (14) and (16) against Salmonella typhi (d), (9) against Staphylococcus aureus (e) and, (14) and (16) against Bacillus subtilis (f) fungal strains. The brine shrimp (Artemia salina) bioassay was also carried out to study their in-vitro cytotoxic properties. Only three compounds, (6), (10) and (23) displayed potent cytotoxic activity with LD50 = 1.8535 x 10(-4), 1.8173 x 10(-4) and 1.9291 x 10(-4) respectively.     

Synthesis, structure and biological activity of cobalt(II) and copper(II) complexes of valine-derived schiff bases

We have synthesized two cobalt(II) 2 and copper(II) 3 complexes of valine-derived Schiff bases. The obtained complexes were characterized by elemental analysis, FT-IR and X-ray diffraction. Biological studies of complexes 2 and 3 had been carried out in vitro for antimicrobial activity against Gram-positive, Gram-negative bacteria and human pathogenic fungi. Compound 3 was proven to be a broad spectrum agent, showed a significant inhibition of the growth of Gram-positive bacteria (Staphylococcus aureus, methicillin-resistant S. aureus, Bacillus subtilis, Micrococcus luteus), and pathogenic fungi (Candida spp., Cryptococcus neoformans, Rhodothece glutinis, Saccharomyces cerevisia, Aspergillus spp., Rhizopus nigricans) tested and a moderate activity against Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa, Proteus vulgaris and Enterobacter aerogenes) tested. The in vitro cytotoxicity of compound 3 was evaluated using hemolytic assay, in which the compound 3 was found to be non-toxic to human erythrocytes even at a concentration of 500mug/mL.     

西瓜藤提取物的抑菌作用研究

采用琼脂稀释法研究西瓜藤提取物的体外抑菌作用,用小鼠腹腔注射金黄色葡萄球菌法研究80%醇提物的体内抑菌作用。结果表明:西瓜藤提取物对金黄色葡萄球菌、大肠埃希氏菌、铜绿假单胞菌、伤寒沙门氏菌、枯草芽孢杆菌和肺炎克雷伯氏菌均有不同程度的抑制作用,但对链球菌作用不明显。其中80%醇提取物和乙酸乙酯萃取物抑制金黄色葡萄球菌活性最好,其最低抑菌浓度(MIC)分别为4.2、8.4mg.mL-1。体内实验也表明,乙醇提取物具有较好的抑菌作用。西瓜藤提取物具有抑菌活性,在抑菌方面有一定开发前景。     

Synthesis and antimicrobial properties of imidazolium and pyrrolidinonium salts

For the purpose of developing new disinfectants and antiseptics, we searched for compounds having high bactericidal activity against gram-positive bacteria, gram-negative bacteria, and fungi. Three different series of quaternary imidazolium and pyrrolidinonium salts were synthesized: series A (1-alkyl-3-methylimidazolium chlorides and bromides); series B (1-alkyl-2-methyl-3-hydroxyethylimidazolium chlorides); and series C (N-alkyl-N-hydroxyethylpyrrolidinonium). Series B and C were newly designed. These three series were tested to evaluate their antibacterial and antifungal properties for the first time. Seven microbial strains were used in the study: Escherichia coli KCTC1924, Salmonella typhimurium KCTC1926, Staphylococcus aureus 209 KCTC1916, Staphylococcus aureus R209 KCTC1928, Bacillus subtilis KCTC1914, Candida albicans KCTC1940, and Chlorella regularis. The antimicrobial efficiency was measured by bacterial and fungal growth inhibition expressed as minimal inhibitory concentration (MIC) values. Series A and B imidazolium salts had very good antimicrobial activity against the examined Gram-negative bacteria, Gram-positive bacteria, and fungi. Also the pyrrolidinonium salt was found to have low MIC for some of tested microorganisms. The antibacterial and antifungal active properties of the salts depend upon the structure of functional groups and the alkyl chain length in the imidazolium and pyrrolidinonium ring. Among the synthesized quaternary imidazolium and pyrrolidinonium salts, the imidazolium salts containing a long alkyl chain and the introduction of a hydroxyethyl chain and methyl group into the imidazolium ring structure leads to broad spectrum active antimicrobial agents which not only have bacteriostatic properties but could be powerful bactericides.